The FDA on Friday released a new letter sent last week to BioNTech and Pfizer regarding their quietly held priority review voucher. Despite the fact that the company could’ve collected the voucher after winning approval for their Covid-19 vaccine in August, the letter was released just a day after BioNTech’s...